262 related articles for article (PubMed ID: 29046368)
1. Enhancement of lung gene delivery after aerosol: a new strategy using non-viral complexes with antibacterial properties.
Mottais A; Le Gall T; Sibiril Y; Ravel J; Laurent V; d'Arbonneau F; Montier T
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046368
[TBL] [Abstract][Full Text] [Related]
2. Aerosolized Medications for Gene and Peptide Therapy.
Laube BL
Respir Care; 2015 Jun; 60(6):806-21; discussion 821-4. PubMed ID: 26070576
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial and transfection activities of nebulized formulations incorporating long n-alkyl chain silver N-heterocyclic carbene complexes.
Mottais A; Berchel M; Le Gall T; Sibiril Y; d'Arbonneau F; Laurent V; Jaffrès PA; Montier T
Int J Pharm; 2019 Aug; 567():118500. PubMed ID: 31288056
[TBL] [Abstract][Full Text] [Related]
4. Arsonium-containing lipophosphoramides, poly-functional nano-carriers for simultaneous antibacterial action and eukaryotic cell transfection.
Le Gall T; Berchel M; Le Hir S; Fraix A; Salaün JY; Férec C; Lehn P; Jaffrès PA; Montier T
Adv Healthc Mater; 2013 Nov; 2(11):1513-24. PubMed ID: 23625809
[TBL] [Abstract][Full Text] [Related]
5. Barriers to inhaled gene therapy of obstructive lung diseases: A review.
Kim N; Duncan GA; Hanes J; Suk JS
J Control Release; 2016 Oct; 240():465-488. PubMed ID: 27196742
[TBL] [Abstract][Full Text] [Related]
6. Challenges and Successes Using Nanomedicines for Aerosol Delivery to the Airways.
Resnier P; Mottais A; Sibiril Y; Le Gall T; Montier T
Curr Gene Ther; 2016; 16(1):34-46. PubMed ID: 26725879
[TBL] [Abstract][Full Text] [Related]
7. Aerosol antibiotics: considerations in pharmacological and clinical evaluation.
Dudley MN; Loutit J; Griffith DC
Curr Opin Biotechnol; 2008 Dec; 19(6):637-43. PubMed ID: 19036576
[TBL] [Abstract][Full Text] [Related]
8. Other medications for aerosol delivery.
Rubin BK
Paediatr Respir Rev; 2006; 7 Suppl 1():S76-9. PubMed ID: 16798603
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of airway targeted PLGA nanoparticles for drug delivery in obstructive lung diseases.
Vij N
Methods Mol Biol; 2012; 906():303-10. PubMed ID: 22791443
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.
Nafee N; Husari A; Maurer CK; Lu C; de Rossi C; Steinbach A; Hartmann RW; Lehr CM; Schneider M
J Control Release; 2014 Oct; 192():131-40. PubMed ID: 24997276
[TBL] [Abstract][Full Text] [Related]
11. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
Kolanjiyil AV; Kleinstreuer C; Sadikot RT
Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
[TBL] [Abstract][Full Text] [Related]
12. Aerosol administration of antibiotics.
Smith AL; Ramsey B
Respiration; 1995; 62 Suppl 1():19-24. PubMed ID: 7792435
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic use in cystic fibrosis.
Eisenberg JD
Curr Opin Pulm Med; 1996 Nov; 2(6):439-46. PubMed ID: 9363182
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic treatment. Aerosol therapy.
Hodson ME
Chest; 1988 Aug; 94(2 Suppl):156S-162S. PubMed ID: 3396438
[TBL] [Abstract][Full Text] [Related]
15. Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin.
Ehsan Z; Clancy JP
Future Microbiol; 2015; 10(12):1901-12. PubMed ID: 26573178
[TBL] [Abstract][Full Text] [Related]
16. Role of antibacterial chemotherapy in the management of chronic bronchial obstructive disease.
Gialdroni-Grassi G
Int J Clin Pharmacol Ther Toxicol; 1980 Oct; 18(10):431-6. PubMed ID: 7203719
[TBL] [Abstract][Full Text] [Related]
17. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
Laube BL
Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
[TBL] [Abstract][Full Text] [Related]
18. Aerosolized Antibiotics.
Restrepo MI; Keyt H; Reyes LF
Respir Care; 2015 Jun; 60(6):762-1; discussion 771-3. PubMed ID: 26070573
[TBL] [Abstract][Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
20. Aerosol delivery of DNA/liposomes to the lung for cystic fibrosis gene therapy.
Davies LA; Nunez-Alonso GA; McLachlan G; Hyde SC; Gill DR
Hum Gene Ther Clin Dev; 2014 Jun; 25(2):97-107. PubMed ID: 24865497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
